Acquisition

Date: 18th September, 2026 To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Towers, Bandra – Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : 532612 Stock Code : INDOCO Dear Sir/Madam, Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Incorporation of Wholly Owned Subsidiary Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Committee of Executive Directors in its meeting held today i.e. 18th September, 2026 has considered and approved the incorporation of the wholly owned subsidiary “Warren Lifesciences Private Limited”, for which the name approval has been received from the Registrar of Companies, Mumbai. The said company shall be incorporated in due course and upon incorporation, it will become a wholly owned subsidiary of the Company. The Committee Meeting commenced today at 05:15 p.m. (IST) and concluded at 05.45 p.m. (IST). Details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January, 2026 are enclosed as Annexure A. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Indoco Remedies Limited Ramanathan Hariharan Company Secretary & Head Legal Annexure A Sr. No. Particulars Details 1 Name of the entity, date & country Name of the Proposed Company of incorporation, etc.; Warren Lifesciences Private Limited Date of Incorporation Yet to be incorporated. The date of incorporation will be intimated upon incorporation. Country of incorporation India 2 Name of holding company of the The proposed company will be a wholly incorporated company and relation owned subsidiary of Indoco Remedies with the listed entity; Limited. 3 Industry to which the entity being Pharmaceutical Sector incorporated belongs; 4 Brief background about the entity The Company intends to manufacture, incorporated in terms of products / develop, sell etc. in pharmaceutical line of business; products including but not limited to active pharmaceutical ingredients, finished formulations, key starting materials. 5 Brief details of any governmental or The incorporation of the proposed regulatory approvals required for company shall be subject to approval of the incorporation; the Registrar of Companies / Ministry of Corporate Affairs and other applicable statutory/regulatory approvals, if any. 6 Nature of consideration - whether Cash Consideration cash consideration or share swap and details of the same; 7 Cost of subscription / price at which The shares will be subscribed at face value the shares are subscribed; of Rs. 10 per share. 8 Percentage of shareholding / control Proposed Authorised and Paid-up Capital: by the listed entity and / or number The proposed authorised and paid up of shares allotted. equity share capital of the proposed company will be Rs. 1,00,000 divided into 10,000 equity shares of Rs. 10/- each. 100% shareholding of the proposed company shall be held by Indoco Remedies Limited.